Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03473249

Effectiveness of Contrast-Enhanced Ultrasound

Clinical Effectiveness of Contrast-Enhanced Ultrasound in the Evaluation of Blunt Abdominal Trauma in Young Children

Status
Active Not Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
0 Years – 7 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to generate pilot data describing test characteristics of contrast enhanced ultrasound in young children with concern for abdominal trauma. The primary objective in this study is to determine the sensitivity and specificity of contrast-enhanced ultrasound (CEUS) compared to abdominal Computed Tomography (CT) in the detection of abdominal solid organ injury in young children \< 8 years of age with concern for blunt abdominal trauma.

Detailed description

Abdominal trauma in children can be deadly, but intra-abdominal injuries can be difficult to detect and often lack external signs of injury on physical exam. The current gold standard imaging study is Computed Tomography (CT) with IV contrast, which is associated with radiation exposure. Contrast-enhanced ultrasound is a radiation-free alternative to detect abdominal injuries and has been studied primarily in adults and some older children, but evidence to support its use in young children is needed. This is a prospective study of children less than 8 years of age who are clinically stable and undergoing an abdominal CT with IV contrast as part of their clinical care due to concerns for abdominal trauma. Investigators will compare CEUS results with those obtained by CT. Investigators will additionally include retrospective data of children who underwent both abdominal CT and CEUS as part of clinical care.

Conditions

Interventions

TypeNameDescription
DRUGContrast-Enhanced Ultrasound using LumasonSubjects will undergo a contrast enhanced ultrasound (CEUS) during which a standard greyscale abdominal ultrasound is performed first followed by injection of intravenous contrast with Lumason, and completion of contrast-enhanced ultrasound

Timeline

Start date
2018-05-09
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2018-03-22
Last updated
2025-12-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03473249. Inclusion in this directory is not an endorsement.